Change in Composition of Audit & Risk Committee

 

CLINUVEL PHARMACEUTICALS LTD today announced that non-executive Director, Willem Blijdorp has replaced Managing Director and Chief Executive Officer, Dr Philippe Wolgen as a member of the Audit & Risk Committee.

Download PDF

We use cookies to give you the best experience.